UNSPSC 51391747: Arformoterol

This classification denotes a beta-adrenergic agonist with the molecular formula C19H24N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, F91H02EBWT chemically known as formamide, n-(2-hydroxy-5-((1r)-1-hydroxy-2-(((1r)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)-, (2r,3r)-2,3-dihydroxybutanedioate (1:1) but generally known as arformoterol, which bears US NIH Compound Identifier 3083544.

UNSPSC 51391747 Arformoterol is a Commodity code for a specific pharmaceutical product, but the recent state and local opportunity tagged to it — Seminole County, Florida's IFB60459723LAS for Naloxone and Safe Drug Deactivation Systems — does not match the code's scope. The posted solicitation seeks naloxone kits and drug disposal systems for community health initiatives, not arformoterol (a long-acting beta-2 agonist bronchodilator). The mismatch suggests either a tagging error in the source record or a misalignment between the UNSPSC code assignment and the actual product being procured. State and local procurement records show no other recent opportunities under this code.

Without recent opportunities that actually align with arformoterol procurement, this code presents minimal decision-relevant activity to evaluate. A business development professional pursuing pharmaceutical supply contracts with state and local health departments, county health systems, or other public health agencies should verify whether arformoterol demand exists through direct outreach to target agencies rather than relying on this code's recent posting history.